世界の骨および関節の健康成分市場調査レポート：2027年までの予測

出版：Market Research Future（マーケットリサーチフューチャー）　出版年月：2022年12月

Bone And Joint Health Ingredient Market Global Research Report Forecast till 2027
世界の骨および関節の健康成分市場調査レポート：　2027年までの予測

レポート目次　　　　お問合せ・ご注文　　　　価格・納期について

Bone And Joint Health Ingredient Market Global Research Report Forecast till 2027

Market Overview
The market for bone and joint health ingredients is anticipated to grow at a 7.69% CAGR and reach USD 28,481.78 million in value by 2027. The increasing prevalence of bone and joint disorders and the rising demand for bone and joint health ingredients among the elderly population in functional foods, beverages, and dietary supplements are both factors contributing to the growth of the global market for bone and joint health ingredients. However, growing consumer knowledge of the negative consequences of goods containing ingredients for bone and joint health could slow market expansion. Additionally, the developing markets for ingredients that promote bone and joint health present potential chances for market expansion in the future.
The market is anticipated to expand because of the rising demand for bone and joint health elements in functional food, beverages, and dietary supplements, rising demand from the older population, and the rising prevalence of orthopedic illnesses. However, concerns including adverse reactions to the components for bones and joints and strict government regulations are anticipated to impede market expansion. However, it is anticipated that untapped markets in developing nations, development strategies by important companies, the influence of social media, and creative marketing techniques will lead to profitable expansion.
Segment Overview
The market for ingredients for bone and joint health has been divided into categories based on type, including calcium, collagen, glucosamine, chondroitin, magnesium, and vitamins.
The global market for bone and joint health ingredients has been divided into three application groups: pharmaceuticals, food and beverage, and nutraceuticals & dietary supplements. In 2020, the Nutraceuticals & Dietary Supplements segment held a higher market share of 65.55%, and it is anticipated to experience the greatest CAGR of 8.60% during the following five years.
Regional Analysis
By area, the worldwide Bone and joint health ingredient market have been partitioned into North America, Europe, Asia-Pacific, and the Remainder of the World.
Asia-Pacific is projected to expand at a 8.20% most noteworthy CAGR during the figure time frame. Asia-Pacific is expected to enlist the most noteworthy development rate over the gauge period from this is because of the great frequency of joint pain and osteoporosis, further developing healthcare, expanding per capita extra cash, and expanding bone and joint health mindfulness. Numerous grown-ups dwelling in the district are supposed to experience the ill effects of different muscular problems.
Europe represented the second-biggest market portion of 28.80% of the Bone and joint health ingredient market in 2020. The local market is supposed to enroll a CAGR of 7.07% during the estimate time frame. Europe is expected to observe critical development over the gauge period because of a bigger number of patients experiencing bone and joint-related messes, the accessibility of items in the district, and the developing geriatric populace. The quantity of hip and knee substitution methods has expanded quickly in most OECD nations.
Major Players
Prominent players in the global Bone and joint health ingredient market include DSM (Netherlands), Stratum Nutrition (US), BASF SE (Germany), Archer-Daniels-Midland Company (ADM) (US), s (Ireland), Holista Colltech (Australia), Lonza Group (Switzerland), PharmaZen Limited (New Zealand), Darling Ingredients (US), Bioiberica S.A.U. (Spain).
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

目次

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY 13

2 MARKET INTRODUCTION 14

2.1 SCOPE OF THE STUDY 14

2.2 RESEARCH OBJECTIVE 14

2.3 MARKET STRUCTURE 14

2.4 ASSUMPTIONS & LIMITATIONS 15

3 RESEARCH METHODOLOGY 16

3.1 DATA MINING 16

3.2 SECONDARY RESEARCH 17

3.3 PRIMARY RESEARCH 18

3.4 BREAKDOWN OF PRIMARY RESPONDENTS 19

3.5 FORECASTING TECHNIQUES 19

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 21

3.6.1 BOTTOM-UP APPROACH 22

3.6.2 TOP-DOWN APPROACH 22

3.7 DATA TRIANGULATION 23

3.8 VALIDATION 23

4 MARKET DYNAMICS 24

4.1 OVERVIEW 24

4.2 DRIVERS 25

4.2.1 GROWING DEMAND FOR BONE AND JOINT HEALTH INGREDIENTS IN FUNCTIONAL

FOOD & BEVERAGES AND DIETARY SUPPLEMENTS 25

4.2.2 RISING DEMAND FOR BONE AND JOINT HEALTH INGREDIENTS IN THE ELDERLY POPULATION 25

4.2.3 RISING PREVALENCE OF ORTHOPEDIC DISEASES 26

4.3 RESTRAINT 27

4.3.1 SIDE EFFECTS ASSOCIATED WITH THE BONE AND JOINT INGREDIENTS 27

4.3.2 STRINGENT GOVERNMENT REGULATIONS 27

4.4 OPPORTUNITY 28

4.4.1 UNTAPPED MARKETS IN DEVELOPING ECONOMIES 28

4.4.2 ADOPTION OF GROWTH STRATEGIES BY KEY PLAYERS 29

4.4.3 INFLUENCE OF SOCIAL MEDIA AND INNOVATIVE MARKETING STRATEGIES 29

5 MARKET FACTOR ANALYSIS 30

5.1 VALUE CHAIN ANALYSIS 30

5.1.1 R&D 31

5.1.2 MANUFACTURING 31

5.1.3 DISTRIBUTION 31

5.1.4 MARKETING AND SALES 31

5.2 PORTER’S FIVE FORCES MODEL 32

5.2.1 THREAT OF NEW ENTRANTS 33

5.2.2 BARGAINING POWER OF SUPPLIERS 33

5.2.3 THREAT OF SUBSTITUTES 33

5.2.4 BARGAINING POWER OF BUYERS 33

5.2.5 INTENSITY OF RIVALRY 33

5.3 COVID-19 IMPACT ANALYSIS 34

5.3.1 IMPACT ON R&D 34

5.3.2 IMPACT ON SUPPLY CHAIN 34

5.3.3 IMPACT ON RAW MATERIAL 34

5.3.4 IMPACT ON DEMAND AND SUPPLY 35

6 GLOBAL BONE AND JOINT HEALTH INGREDIENT MARKET, BY INGREDIENT TYPE 36

6.1 OVERVIEW 36

6.2 CALCIUM 37

6.3 COLLAGEN 39

6.4 GLUCOSAMINE 40

6.5 CHONDROITIN 41

6.6 MAGNESIUM 42

6.7 VITAMINS 43

6.8 OTHERS 45

7 GLOBAL BONE AND JOINT HEALTH INGREDIENT MARKET, BY APPLICATION 46

7.1 OVERVIEW 46

7.2 FOOD & BEVERAGES 47

7.3 PHARMACEUTICALS 48

7.4 NUTRACEUTICALS & DIETARY SUPPLEMENTS 49

8 GLOBAL BONE AND JOINT HEALTH INGREDIENT MARKET, BY REGION 50

8.1 OVERVIEW 50

8.2 NORTH AMERICA 52

8.2.1 US 54

8.2.2 CANADA 55

8.2.3 MEXICO 56

8.3 EUROPE 57

8.3.1 GERMANY 59

8.3.2 UK 60

8.3.3 FRANCE 61

8.3.4 ITALY 62

8.3.5 SPAIN 63

8.3.6 REST OF EUROPE 64

8.4 ASIA PACIFIC 65

8.4.1 CHINA 67

8.4.2 JAPAN 68

8.4.3 INDIA 69

8.4.4 AUSTRALIA & NEW ZEALAND 70

8.4.5 REST OF ASIA-PACIFIC 71

8.5 REST OF THE WORLD 72

8.5.1 SOUTH AMERICA 74

8.5.2 MIDDLE EAST 75

8.5.3 AFRICA 76

9 COMPETITIVE LANDSCAPE 77

9.1 OVERVIEW 77

9.2 COMPETITIVE BENCHMARKING 79

9.3 MAJOR GROWTH STRATEGY IN THE BONE AND JOINT HEALTH INGREDIENT MARKET 80

9.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN THE BONE AND JOINT HEALTH INGREDIENT MARKET 81

9.5 KEY DEVELOPMENT ANALYSIS 81

9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 82

9.6.1 PRODUCT LAUNCH/ APPROVAL 82

9.6.2 COLLABORATION/EXPANSION/INVESTMENT/PARTNERSHIP 82

9.6.3 MARKET PROMOTION/PRODUCT RECOGNITION/PRODUCT INCORPORATION 83

9.7 FINANCIAL MATRIX 84

9.7.1 SALES (USD MILLION), 2020 84

9.7.2 R&D EXPENDITURE (USD MILLION), 2020 84

10 COMPANY PROFILES 85

10.1 KONINKLIJKE DSM N.V. (ROYAL DSM) 85

10.1.1 COMPANY OVERVIEWS 85

10.1.2 FINANCIAL OVERVIEW 86

10.1.3 PRODUCTS/SERVICES OFFERED 87

10.1.4 KEY DEVELOPMENTS 87

10.1.5 SWOT ANALYSIS 88

10.1.6 KEY STRATEGIES 88

10.2 BASF SE 89

10.2.1 COMPANY OVERVIEW 89

10.2.2 FINANCIAL OVERVIEW 90

10.2.3 PRODUCTS/SERVICES OFFERED 90

10.2.4 KEY DEVELOPMENTS 91

10.2.5 SWOT ANALYSIS 91

10.2.6 KEY STRATEGIES 91

10.3 ARCHER DANIELS MIDLAND 92

10.3.1 COMPANY OVERVIEWS 92

10.3.2 FINANCIAL OVERVIEW 93

10.3.3 PRODUCTS/SERVICES OFFERED 93

10.3.4 KEY DEVELOPMENTS 93

10.3.5 SWOT ANALYSIS 94

10.3.6 KEY STRATEGIES 94

10.4 GLANBIA PLC 95

10.4.1 COMPANY OVERVIEWS 95

10.4.2 FINANCIAL OVERVIEW 96

10.4.3 PRODUCTS/SERVICES OFFERED 96

10.4.4 KEY DEVELOPMENTS 97

10.4.5 SWOT ANALYSIS 97

10.4.6 KEY STRATEGIES 97

10.5 LONZA GROUP 98

10.5.1 COMPANY OVERVIEWS 98

10.5.2 FINANCIAL OVERVIEW 99

10.5.3 PRODUCTS/SERVICES OFFERED 99

10.5.4 KEY DEVELOPMENTS 100

10.5.5 SWOT ANALYSIS 101

10.5.6 KEY STRATEGIES 101

10.6 BIOIBERICA S.A.U. 102

10.6.1 COMPANY OVERVIEWS 102

10.6.2 FINANCIAL OVERVIEW 102

10.6.3 PRODUCTS/SERVICES OFFERED 102

10.6.4 KEY DEVELOPMENTS 103

10.6.5 SWOT ANALYSIS 103

10.6.6 KEY STRATEGIES 104

10.7 STRATUM NUTRITION 105

10.7.1 COMPANY OVERVIEW 105

10.7.2 FINANCIAL OVERVIEW 105

10.7.3 PRODUCTS/SERVICES OFFERED 105

10.7.4 KEY DEVELOPMENTS 105

10.7.5 KEY STRATEGIES 105

10.8 PHARMAZEN LIMITED (WAITAKI BIO) 106

10.8.1 COMPANY OVERVIEW 106

10.8.2 FINANCIAL OVERVIEW 106

10.8.3 PRODUCTS/SERVICES OFFERED 107

10.8.4 KEY DEVELOPMENTS 107

10.8.5 KEY STRATEGIES 107

10.9 DARLING INGREDIENTS (ROUSSELOT) 108

10.9.1 COMPANY OVERVIEW 108

10.9.2 FINANCIAL OVERVIEW 109

10.9.3 PRODUCTS/SERVICES OFFERED 109

10.9.4 KEY DEVELOPMENTS 110

10.9.5 KEY STRATEGIES 110

10.10 HOLISTA COLLTECH 111

10.10.1 COMPANY OVERVIEWS 111

10.10.2 FINANCIAL OVERVIEW 112

10.10.3 PRODUCTS/SERVICES OFFERED 112

10.10.4 DEVELOPMENTS 113

10.10.5 KEY STRATEGIES 113

11 APPENDIX 114

11.1 REFERENCES 114

11.2 RELATED REPORTS 114

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 15

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 18

TABLE 3 GLOBAL: BONE AND JOINT HEALTH INGREDIENT MARKET, BY INGREDIENT TYPE, 2018-2027 (USD MILLION) 37

TABLE 4 AMOUNTS OF CALCIUM REQUIRED FOR BONE HEALTH AND TO MAINTAIN ADEQUATE

RATES OF CALCIUM RETENTION IN HEALTHY PEOPLE 37

TABLE 5 MAJOR CALCIUM SOURCE OF SELECTED FOODS 38

TABLE 6 GLOBAL: BONE AND JOINT HEALTH INGREDIENT MARKET, FOR CALCIUM, BY REGION, 2018-2027 (USD MILLION) 38

TABLE 7 GLOBAL: BONE AND JOINT HEALTH INGREDIENT MARKET, FOR COLLAGEN, BY REGION, 2018-2027 (USD MILLION) 39

TABLE 8 GLOBAL: BONE AND JOINT HEALTH INGREDIENT MARKET, FOR GLUCOSAMINE, BY REGION, 2018-2027 (USD MILLION) 40

TABLE 9 GLOBAL: BONE AND JOINT HEALTH INGREDIENT MARKET, FOR CHONDROITIN, BY REGION, 2018-2027 (USD MILLION) 41

TABLE 10 AMOUNTS OF MAGNESIUM REQUIRED FOR PROPER FUNCTIONING IN HEALTHY PEOPLE 42

TABLE 11 GLOBAL: BONE AND JOINT HEALTH INGREDIENT MARKET, FOR MAGNESIUM, BY REGION, 2018-2027 (USD MILLION) 43

TABLE 12 AVERAGE DAILY RECOMMENDED AMOUNTS OF VITAMIN C FOR DIFFERENT AGES IN MILLIGRAMS (MG) 43

TABLE 13 DAILY UPPER LIMITS FOR VITAMIN C CONSUMPTION (MG) 44

TABLE 14 VITAMIN C CONTENT OF SELECTED FOODS 44

TABLE 15 GLOBAL: BONE AND JOINT HEALTH INGREDIENT MARKET, FOR VITAMINS, BY REGION, 2018-2027 (USD MILLION) 45

TABLE 16 GLOBAL: BONE AND JOINT HEALTH INGREDIENT MARKET, FOR OTHERS, BY REGION, 2018-2027 (USD MILLION) 45

TABLE 17 GLOBAL: BONE AND JOINT HEALTH INGREDIENT MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 46

TABLE 18 GLOBAL: BONE AND JOINT HEALTH INGREDIENT MARKET FOR FOOD & BEVERAGES, BY REGION, 2018-2027 (USD MILLION) 47

TABLE 19 GLOBAL: BONE AND JOINT HEALTH INGREDIENT MARKET, FOR PHARMACEUTICALS, BY REGION, 2018-2027 (USD MILLION) 48

TABLE 20 GLOBAL: BONE AND JOINT HEALTH INGREDIENT MARKET, FOR NUTRACEUTICALS & DIETARY

SUPPLEMENTS, BY REGION, 2018-2027, (USD MILLION) 49

TABLE 21 GLOBAL: BONE AND JOINT HEALTH INGREDIENT MARKET, BY REGION, 2018-2027 (USD MILLION) 51

TABLE 22 NORTH AMERICA: BONE AND JOINT HEALTH INGREDIENT MARKET, BY COUNTRY, 2018-2027 (USD MILLION) 52

TABLE 23 NORTH AMERICA: BONE AND JOINT HEALTH INGREDIENT MARKET, BY INGREDIENT TYPE, 2018-2027 (USD MILLION) 53

TABLE 24 NORTH AMERICA: BONE AND JOINT HEALTH INGREDIENT MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 54

TABLE 25 US: BONE AND JOINT HEALTH INGREDIENT MARKET, BY INGREDIENT TYPE, 2018-2027 (USD MILLION) 54

TABLE 26 US: BONE AND JOINT HEALTH INGREDIENT MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 54

TABLE 27 CANADA: BONE AND JOINT HEALTH INGREDIENT MARKET, BY INGREDIENT TYPE, 2018-2027 (USD MILLION) 55

TABLE 28 CANADA: BONE AND JOINT HEALTH INGREDIENT MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 55

TABLE 29 MEXICO: BONE AND JOINT HEALTH INGREDIENT MARKET, BY INGREDIENT TYPE, 2018-2027 (USD MILLION) 56

TABLE 30 MEXICO: BONE AND JOINT HEALTH INGREDIENT MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 56

TABLE 31 EUROPE: BONE AND JOINT HEALTH INGREDIENT MARKET, BY COUNTRY, 2018-2027 (USD MILLION) 57

TABLE 32 EUROPE: BONE AND JOINT HEALTH INGREDIENT MARKET, BY INGREDIENT TYPE, 2018-2027 (USD MILLION) 58

TABLE 33 EUROPE: BONE AND JOINT HEALTH INGREDIENT MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 59

TABLE 34 GERMANY: BONE AND JOINT HEALTH INGREDIENT MARKET, BY INGREDIENT TYPE, 2018-2027 (USD MILLION) 59

TABLE 35 GERMANY: BONE AND JOINT HEALTH INGREDIENT MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 59

TABLE 36 UK: BONE AND JOINT HEALTH INGREDIENT MARKET, BY INGREDIENT TYPE, 2018-2027 (USD MILLION) 60

TABLE 37 UK: BONE AND JOINT HEALTH INGREDIENT MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 60

TABLE 38 FRANCE: BONE AND JOINT HEALTH INGREDIENT MARKET, BY INGREDIENT TYPE, 2018-2027 (USD MILLION) 61

TABLE 39 FRANCE: BONE AND JOINT HEALTH INGREDIENT MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 61

TABLE 40 ITALY: BONE AND JOINT HEALTH INGREDIENT MARKET, BY INGREDIENT TYPE, 2018-2027 (USD MILLION) 62

TABLE 41 ITALY: BONE AND JOINT HEALTH INGREDIENT MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 62

TABLE 42 SPAIN: BONE AND JOINT HEALTH INGREDIENT MARKET, BY INGREDIENT TYPE, 2018-2027 (USD MILLION) 63

TABLE 43 SPAIN: BONE AND JOINT HEALTH INGREDIENT MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 63

TABLE 44 REST OF EUROPE: BONE AND JOINT HEALTH INGREDIENT MARKET, BY INGREDIENT TYPE, 2018-2027 (USD MILLION) 64

TABLE 45 REST OF EUROPE: BONE AND JOINT HEALTH INGREDIENT MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 64

TABLE 46 ASIA-PACIFIC: BONE AND JOINT HEALTH INGREDIENT MARKET, BY COUNTRY, 2018-2027 (USD MILLION) 65

TABLE 47 ASIA-PACIFIC: BONE AND JOINT HEALTH INGREDIENT MARKET, BY INGREDIENT TYPE, 2018-2027 (USD MILLION) 66

TABLE 48 ASIA-PACIFIC: BONE AND JOINT HEALTH INGREDIENT MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 67

TABLE 49 CHINA: BONE AND JOINT HEALTH INGREDIENT MARKET, BY INGREDIENT TYPE, 2018-2027 (USD MILLION) 67

TABLE 50 CHINA: BONE AND JOINT HEALTH INGREDIENT MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 67

TABLE 51 JAPAN: BONE AND JOINT HEALTH INGREDIENT MARKET, BY INGREDIENT TYPE, 2018-2027 (USD MILLION) 68

TABLE 52 JAPAN: BONE AND JOINT HEALTH INGREDIENT MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 68

TABLE 53 INDIA: BONE AND JOINT HEALTH INGREDIENT MARKET, BY INGREDIENT TYPE, 2018-2027 (USD MILLION) 69

TABLE 54 INDIA: BONE AND JOINT HEALTH INGREDIENT MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 69

TABLE 55 AUSTRALIA & NEW ZEALAND: BONE AND JOINT HEALTH INGREDIENT MARKET,

BY INGREDIENT TYPE, 2018-2027 (USD MILLION) 70

TABLE 56 AUSTRALIA & NEW ZEALAND: BONE AND JOINT HEALTH INGREDIENT MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 70

TABLE 57 REST OF ASIA-PACIFIC: BONE AND JOINT HEALTH INGREDIENT MARKET, BY INGREDIENT TYPE, 2018-2027 (USD MILLION) 71

TABLE 58 REST OF ASIA-PACIFIC: BONE AND JOINT HEALTH INGREDIENT MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 71

TABLE 59 REST OF THE WORLD: BONE AND JOINT HEALTH INGREDIENT MARKET, BY REGION, 2018-2027 (USD MILLION) 72

TABLE 60 REST OF THE WORLD: BONE AND JOINT HEALTH INGREDIENT MARKET, BY INGREDIENT TYPE, 2018-2027 (USD MILLION) 73

TABLE 61 REST OF THE WORLD: BONE AND JOINT HEALTH INGREDIENT MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 73

TABLE 62 SOUTH AMERICA: BONE AND JOINT HEALTH INGREDIENT MARKET, BY INGREDIENT TYPE, 2018-2027 (USD MILLION) 74

TABLE 63 SOUTH AMERICA: BONE AND JOINT HEALTH INGREDIENT MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 74

TABLE 64 MIDDLE EAST: BONE AND JOINT HEALTH INGREDIENT MARKET, BY INGREDIENT TYPE, 2018-2027 (USD MILLION) 75

TABLE 65 MIDDLE EAST: BONE AND JOINT HEALTH INGREDIENT MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 75

TABLE 66 AFRICA: BONE AND JOINT HEALTH INGREDIENT MARKET, BY INGREDIENT TYPE, 2018-2027 (USD MILLION) 76

TABLE 67 AFRICA: BONE AND JOINT HEALTH INGREDIENT MARKET, BY APPLICATION, 2018-2027 (USD MILLION) 76

TABLE 68 MAJOR MANUFACTURERS IN THE BONE AND JOINT HEALTH INGREDIENT MARKET 78

TABLE 69 MOST ACTIVE PLAYER IN THE BONE AND JOINT HEALTH INGREDIENT MARKET 81

TABLE 70 PRODUCT LAUNCH/ APPROVAL 82

TABLE 71 COLLABORATION/EXPANSION/INVESTMENT/PARTNERSHIP 82

TABLE 72 MARKET PROMOTION/PRODUCT RECOGNITION/PRODUCT INCORPORATION 83

TABLE 73 DSM: PRODUCTS/SERVICES OFFERED 87

TABLE 74 DSM: KEY DEVELOPMENTS 87

TABLE 75 BASF SE: PRODUCTS/SERVICES OFFERED 90

TABLE 76 BASF SE: KEY DEVELOPMENTS 91

TABLE 77 ADM: PRODUCTS/SERVICES OFFERED 93

TABLE 78 GLANBIA PLC.: PRODUCTS/SERVICES OFFERED 96

TABLE 79 GLANBIA PLC.: KEY DEVELOPMENTS 97

TABLE 80 LONZA GROUP: PRODUCTS/SERVICES OFFERED 99

TABLE 81 LONZA GROUP: KEY DEVELOPMENTS 100

TABLE 82 BIOIBERICA S.A.U.: PRODUCTS/SERVICES OFFERED 102

TABLE 83 BIOIBERICA S.A.U.: KEY DEVELOPMENTS 103

TABLE 84 STRATUM NUTRITION: PRODUCTS/SERVICES OFFERED 105

TABLE 85 PHARMAZEN LIMITED: PRODUCTS/SERVICES OFFERED 107

TABLE 86 PHARMAZEN LIMITED: KEY DEVELOPMENTS 107

TABLE 87 DARLING INGREDIENTS.: PRODUCTS/SERVICES OFFERED 109

TABLE 88 DARLING INGREDIENTS: KEY DEVELOPMENTS 110

TABLE 89 HOLISTA COLLTECH: PRODUCTS/SERVICES OFFERED 112

LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS 13

FIGURE 2 GLOBAL BONE AND JOINT HEALTH INGREDIENT MARKET 14

FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES 21

FIGURE 4 DYNAMICS: GLOBAL BONE AND JOINT HEALTH INGREDIENT MARKET 24

FIGURE 5 DRIVERS: IMPACT ANALYSIS 26

FIGURE 6 RESTRAINT: IMPACT ANALYSIS 28

FIGURE 7 VALUE CHAIN ANALYSIS: GLOBAL BONE AND JOINT HEALTH INGREDIENT MARKET 30

FIGURE 8 PORTER’S FIVE FORCES ANALYSIS: GLOBAL BONE AND JOINT HEALTH INGREDIENT MARKET 32

FIGURE 9 GLOBAL BONE AND JOINT HEALTH INGREDIENT MARKET, BY INGREDIENT TYPE, 2020 & 2027 (USD MILLION) 36

FIGURE 10 GLOBAL: BONE AND JOINT HEALTH INGREDIENT MARKET, BY APPLICATION, 2020 & 2027 (USD MILLION) 46

FIGURE 11 GLOBAL: BONE AND JOINT HEALTH INGREDIENT MARKET, BY REGION 2020 & 2027 (USD MILLION) 50

FIGURE 12 GLOBAL: BONE AND JOINT HEALTH INGREDIENT MARKET SHARE (%), BY REGION, 2020 51

FIGURE 13 NORTH AMERICA: BONE AND JOINT HEALTH INGREDIENT MARKET SHARE (%), BY COUNTRY 2020 53

FIGURE 14 EUROPE: BONE AND JOINT HEALTH INGREDIENT MARKET SHARE (%), BY COUNTRY, 2020 58

FIGURE 15 ASIA-PACIFIC: BONE AND JOINT HEALTH INGREDIENT MARKET SHARE (%), BY COUNTRY, 2020 66

FIGURE 16 REST OF THE WORLD: BONE AND JOINT HEALTH INGREDIENT MARKET SHARE (%), BY REGION, 2020 72

FIGURE 17 BENCHMARKING OF MAJOR COMPETITORS 79

FIGURE 18 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE BONE AND JOINT HEALTH INGREDIENT MARKET 80

FIGURE 19 GLOBAL BONE AND JOINT HEALTH INGREDIENT MARKET: COMPETITIVE LANDSCAPE 81

FIGURE 20 SALES (USD MILLION), 2020 84

FIGURE 21 R&D EXPENDITURE (USD MILLION), 2020 84

FIGURE 22 DSM: FINANCIAL OVERVIEW SNAPSHOT 86

FIGURE 23 DSM: SWOT ANALYSIS 88

FIGURE 24 BASF SE: FINANCIAL OVERVIEW SNAPSHOT 90

FIGURE 25 BASF SE: SWOT ANALYSIS 91

FIGURE 26 ADM: FINANCIAL OVERVIEW SNAPSHOT 93

FIGURE 27 ADM: SWOT ANALYSIS 94

FIGURE 28 GLANBIA PLC: FINANCIAL OVERVIEW SNAPSHOT 96

FIGURE 29 GLANBIA PLC.: SWOT ANALYSIS 97

FIGURE 30 LONZA GROUP: FINANCIAL OVERVIEW SNAPSHOT 99

FIGURE 31 LONZA GROUP: SWOT ANALYSIS 101

FIGURE 32 BIOIBERICA S.A.U.: SWOT ANALYSIS 103

FIGURE 33 PHARMAZEN LIMITED: FINANCIAL OVERVIEW SNAPSHOT 106

FIGURE 34 DARLING INGREDIENTS: FINANCIAL OVERVIEW SNAPSHOT 109

FIGURE 35 HOLISTA COLLTECH: FINANCIAL OVERVIEW SNAPSHOT 112